Skip to main content

Table 1 Baseline demographics of the included patients (N = 367)

From: Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms

 

ACRN group

(N = 264)

ASP group

(N = 33)

HRP group

(N = 70)

p value

Age < 50 years

51 (19%)

15 (45%)

15 (21%)

0.006

Male

180 (68%)

22 (67%)

55 (79%)

0.207

Obesity

101 (39%)

10 (32%)

32 (46%)

0.353

Visceral obesity

36 (16%)

3 (10%)

13 (21%)

0.449

Comorbidity

 Hypertension

77 (29%)

4 (12%)

28 (40%)

0.012

 Diabetes

37 (14%)

0

16 (23%)

0.004

 Dyslipidemia

50 (19%)

4 (12%)

15 (21%)

0.531

Medications

 Aspirin

25 (9%)

0

11 (16%)

0.030

 Statins

34 (13%)

3 (9%)

13 (19%)

0.361

 Metformin

21 (8%)

0

8 (11%)

0.116

Current smoker

82 (31%)

8 (25%)

19 (27%)

0.700

Alcohol intake

137 (52%)

16 (49%)

54 (77%)

< 0.001

Family history of CRC

27 (10%)

4 (13%)

7 (10%)

0.883

  1. ACRN advanced colorectal neoplasm, ASP advanced serrated polyps, HRP high-risk polyps, CRC colorectal cancer